Millie
your market intelligence analyst
Search Results
491 results
Your search is now limited to «Cancer Drugs» expert search.
PharmiWeb.com 07/18/2019 07:36
On the basis of cancer type, the cancer immunotherapy drug discovery outsourcing market is segmented into lung, breast, colorectal, melanoma, prostate, head and neck, ovarian and pancreatic.
More from PharmiWeb.com:
ecancer news 07/18/2019 01:00
When the cancer cells metabolise the hidden drug, they die.
More from ecancer news:
pharmaphorum 07/17/2019 06:41
Seattle Genetics and Astellas have filed their antibody-drug conjugate enfortumab vedotin with the US drug regulator for advanced bladder cancer, after failure of chemotherapy and immunotherapy.
More from pharmaphorum:
PMLiVE 07/16/2019 19:12
Novartis’ Kisqali has been recommended for use on the Cancer Drugs Fund (CDF) for second line use in combination with fulvestrant in advanced breast cancer.
More from PMLiVE:
Becker's Hospital Review 07/16/2019 11:30
The Netherlands is testing a "no cure, no pay" reimbursement model for expensive cancer drugs, according to Medscape.
More from Becker's Hospital Review:
Xconomy 07/16/2019 10:31
The deal with Genentech, a Roche subsidiary, calls for Cambridge, MA-based Skyhawk to use its technology to discover and develop RNA-targeting drugs for cancer and neurological diseases.
More from Xconomy:
AstraZeneca’s oncology immunotherapy Imfinzi (durvalumab) has been granted orphan drug designation (ODD) for the treatment of small cell lung cancer (SCLC.
More from Pharmaceutical Business Review:
Technology Org 07/15/2019 09:50
These results also suggest that LPCAT1 may be a very compelling new drug target in a wide variety of cancer types.
More from Technology Org:
ClinicalTrials.gov 07/15/2019 09:39
Conditions : Prostate Cancer; Prostate Adenocarcinoma; Prostate Neoplasm; Prostate Cancer Metastatic; Castration-resistant Prostate Cancer Interventions : Drug: Talazoparib; Drug: Temozolomide Sponsor : Memorial Sloan Kettering Cancer Center Recruiting.
More from ClinicalTrials.gov:
Reuters.com 07/15/2019 08:27
GSK has been focusing on bolstering its cancer drug pipeline, and earlier this year agreed to pay up to 3.7 billion euros ($4.17 billion) to Germany’s Merck KGaA for the rights to a next-generation immunotherapy.
More from Reuters.com:
STAT 07/15/2019 06:00
The largest study to date of a “cancer vaccine” plus one of the immunotherapy drugs that has revolutionized cancer treatment found that they kept patients’ tumors in check longer, on average, than drugs alone, but that the benefit was still only a few months for two forms of cancer, study ...
More from STAT:
The FDA approval of IsoTherapeutics to produce a commercial drug product is one of several milestone catalysts we expect to positively impact our business over the next few months," stated Q BioMed CEO Denis Corin.
More from Middle East North Africa Financial Network (MENAFN):
ENDPOINTS 07/12/2019 10:35
When the company decided to take their drug into human clinical trials and start raising funds, Ling stepped up to the challenge.
More from ENDPOINTS:
Healio News 07/12/2019 09:25
FDA accepts new drug application for H. pylori therapy, gastric cancer rates higher among patients treated for H. pylori.
More from Healio News:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications